Ning, Y., Suzman, D., Maher, V. E., Zhang, L., Tang, S., Ricks, T., . . . Pazdur, R. (2017). FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum‐Containing Chemotherapy. Oncologist.
Styl cytowania ChicagoNing, Yang‐Min, et al. "FDA Approval Summary: Atezolizumab for the Treatment of Patients With Progressive Advanced Urothelial Carcinoma After Platinum‐Containing Chemotherapy." Oncologist 2017.
Styl cytowania MLANing, Yang‐Min, et al. "FDA Approval Summary: Atezolizumab for the Treatment of Patients With Progressive Advanced Urothelial Carcinoma After Platinum‐Containing Chemotherapy." Oncologist 2017.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..